J. García-Pagán

R. Groszmann, B. Sharma, S. Sarin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effects of propranolol (Prop) and placebo (Pla) on oesophageal variceal pressure (OVP) in cirrhosis

J. Rodés, J. Bordas, J. Bosch, 1990 .

A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.

P. Tandon, A. Berzigotti, J. Genescà, 2014, Gastroenterology.

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2021, Scientific Reports.

Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients

A. de Gottardi, J. Bosch, J. García‐Pagán, 2008, Alimentary pharmacology & therapeutics.

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

J. Bruix, J. Visa, J. Fuster, 1996, Gastroenterology.

Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

J. Bosch, A. Rodríguez-Vilarrupla, Marina Vilaseca, 2013, Journal of hepatology.

Pathophysiology of portal hypertension.

P. Pizcueta, J. Bosch, Mercedes Fernandez, 1992, Gastroenterology clinics of North America.

Portal hypertension has no role in perioperative bleeding during liver transplantation with systematic porto-caval shunt.

C. Fondevila, J. García-Valdecasas, E. Reverter, 2023, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases].

E. Montserrat, J. Bosch, C. Rozman, 1996, Medicina clinica.

Hepatic fibrin-ring granulomas in a patient with hepatitis A.

J. Bruix, J. García-Pagán, J. Rodés, 1991, Gastroenterology.

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

J. Rodés, J. Bosch, J. García-Pagán, 1995, The Lancet.

Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

R. Bataller, V. Arroyo, J. Bosch, 2009, Gastroenterology.

Current concepts on the pathophysiology of portal hypertension.

Mercedes Fernandez, J. Bosch, A. Rodríguez-Vilarrupla, 2007, Annals of hepatology.

Influence of Pharmacological Agents on Portal Hemodynamics: Basis for Its Use in the Treatment of Portal Hypertension

J. Bosch, J. García‐Pagán, E. Moitinho, 1999, Seminars in liver disease.

Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.

J. Bosch, M. Guillaume, A. Rodríguez-Vilarrupla, 2013, Journal of hepatology.

Insulin resistance and liver microcirculation in a rat model of early NAFLD.

J. Bosch, J. Abraldes, M. Pasarín, 2011, Journal of hepatology.

[The applicability and diagnostic effectiveness of transjugular liver biopsy].

J. Rodés, J. Bosch, J. García-Pagán, 1996, Medicina clinica.

Selective arterial embolization for life threatening hemobilia after transjugular intrahepatic portosystemic shunt placement.

J. Bosch, E. Moitinho, J. García-Pagán, 2001, Journal of hepatology.

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

R. Groszmann, A. Burroughs, J. Bosch, 2002, Gut.

Potential role of antioxidants in the treatment of portal hypertension.

J. Bosch, A. Rodríguez-Vilarrupla, J. García-Pagán, 2007, Journal of hepatology.

Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.

R. Brandes, Mercedes Fernandez, B. Lavina, 2007, Gastroenterology.

A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis

R. Bataller, V. Arroyo, M. Domínguez, 2008, The American Journal of Gastroenterology.

P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis.

P. Pizcueta, J. Panés, P. Engel, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

J. Rodés, J. García‐Pagán, J. Bosch, 1995, Gastroenterology.

103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor

R. Makuch, R. Groszmann, A. Burroughs, 2003 .

Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patient with cirrhosis.

R. Makuch, J. Bosch, D. Patch, 2005 .

Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension

J. Bosch, J. Lozano, Albert Gibert-Ramos, 2023, JHEP reports : innovation in hepatology.

Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.

M. Mejías, E. García-Pras, J. García‐Pagán, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial

P. Hayes, Ferran Torres, J. Genescà, 2023, Hepatology.

Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.

J. Rodés, J. Bordas, J. Bosch, 1993, Gastroenterology.

Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients.

W. Jiménez, J. Rodés, J. Bosch, 1998, Journal of hepatology.

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis

J. Llach, W. Jiménez, M. Navasa, 1993, Hepatology.

[Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].

M. Navasa, J. García-Pagán, J. Bosch, 1992, Medicina clinica.

Increasing intra‐abdominal pressure increases pressure, volume, and wall tension in esophageal varices

J. Llach, J. Bordas, J. Bosch, 2002, Hepatology.

Endoscopic measurement of variceal pressure (VP) in patients with cirrhosis. Correlation with the niec index (NI) and with the risk of variceal hemorrhage

J. Rodés, J. Bordas, J. Bosch, 1990 .

Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

J. Bosch, Marina Vilaseca, J. García-Pagán, 2013, Journal of hepatology.

Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.

J. Bosch, M. Guillaume, J. García-Pagán, 2013, Journal of hepatology.

Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension

J. García-Pagán, Donald D. Heistad, A. Rodrı́guez-Vilarrupla, 2008, Gut.

Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability

Mercedes Fernandez, B. Lavina, J. Bosch, 2007, Hepatology.

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.

W. Jiménez, V. Arroyo, F. Rivera, 1992, Gastroenterology.

Lack of endothelial autophagy does not impair liver regeneration after partial hepatectomy in mice

V. Hernández-Gea, Maria Ruart, J. García-Pagán, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Pharmacological prevention of variceal bleeding. New developments.

J. Bosch, J. García-Pagán, 1997, Bailliere's clinical gastroenterology.